Zymeworks shares are trading higher after Wells Fargo raised its price target on the stock from $34 to $37.
Zymeworks shares are trading higher after Wells Fargo raised its price target on the stock from $34 to $37.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.